PER 5.00% 10.5¢ percheron therapeutics limited

Ann: ATL1102 Early Access Program for Patients with MS, page-72

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,396 Posts.
    lightbulb Created with Sketch. 1438
    Zoomy you pressed the sell button at sub 9c...your just bitter that Anp are ticking all the boxes and is now derisked....No need for The Diamond to do a CR,until mid 2017 and beyond....what's going to kill you is when we get a Large PHARMA to become a Partner for Atl 1102 re MS....everything Anp has said has come true....thus the MS deal will be huge ...the market worth in excess of $14 billion.....
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.